PRIA Logo™
ColoradoHB26-12622026 Regular SessionHouse

Patient Access to Compounded Medical Items

Sponsored By: Dylan Roberts (Democratic), Katie Stewart (Democratic), Matt Ball (Democratic), Rebekah Stewart (Democratic)

Signed by Governor

Health Care & Health InsuranceProfessions & Occupations

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

More supply options for compounded medicines

Licensed people can compound drugs and devices in Colorado in sterile or nonsterile settings. State-licensed pharmacies and eligible 503B outsourcing facilities, both in-state and out-of-state, can supply these items. Licensed health-care providers, pharmacies, facilities, and organizations can obtain, dispense, or administer them. This work must follow federal and state law, including FDA-recognized standards and United States Pharmacopeia sterile or nonsterile processing standards. Compliant compounded items are exempt from the state's new-drug restrictions. Colorado's pharmacy board cannot adopt stricter compounding rules than federal or state law allows. The law does not classify lawful compounding as manufacturing or change the board's existing enforcement authority. These changes apply to conduct on or after the law's effective date. They do not guarantee product availability, lower prices, or insurance coverage.

New drug exemption for qualified research

The law exempts qualifying research drugs from the state's new-drug restrictions. Each drug must be plainly labeled for investigational use only. It must either be intended solely for research by scientifically qualified experts or have an institutional review board's review. Experts must have the training and experience to study drug safety and effectiveness. This exemption does not give patients a general right to receive these drugs.

Sponsors & Cosponsors

Sponsors

  • Dylan Roberts

    Democratic • Senate

  • Katie Stewart

    Democratic • House

  • Matt Ball

    Democratic • Senate

  • Rebekah Stewart

    Democratic • House

Cosponsors

  • Bob Marshall

    Democratic • House

  • Brianna Titone

    Democratic • House

  • Chad Clifford

    Democratic • House

  • Cecelia Espenoza

    Democratic • House

  • Eliza Hamrick

    Democratic • House

  • Emily Sirota

    Democratic • House

  • Jennifer Bacon

    Democratic • House

  • Jamie Jackson

    Democratic • House

  • Junie Joseph

    Democratic • House

  • Julie McCluskie

    Democratic • House

  • Jacque Phillips

    Democratic • House

  • Kyle Brown

    Democratic • House

  • Karen McCormick

    Democratic • House

  • Kenny Nguyen

    Democratic • House

  • Lorena Garcia

    Democratic • House

  • Lesley Smith

    Democratic • House

  • Monica Duran

    Democratic • House

  • Mandy Lindsay

    Democratic • House

  • Manny Rutinel

    Democratic • House

  • Naquetta Ricks

    Democratic • House

  • Ron Weinberg

    Republican • House

  • Sheila Lieder

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 280 • No: 81

House vote • 4/21/2026

Senate amendments: Repass

Yes: 64 • No: 0

House vote • 4/21/2026

Senate amendments: Concur

Yes: 63 • No: 1

Senate vote • 4/17/2026

Third reading: Bill

Yes: 35 • No: 0

Senate vote • 4/9/2026

Refer House Bill 26-1262, as amended, to the Committee of the Whole and with a recommendation that it be placed on the consent calendar.

Yes: 6 • No: 0

House vote • 3/16/2026

Third reading: Bill

Yes: 61 • No: 1

House vote • 3/13/2026

Committee of the whole: Amd (h.002)

Yes: 19 • No: 40

House vote • 3/13/2026

Committee of the whole: Amd (h.001)

Yes: 21 • No: 37

House vote • 3/10/2026

Refer House Bill 26-1262 to the Committee of the Whole.

Yes: 11 • No: 2

Actions Timeline

  1. Governor Signed

    6/2/2026House

  2. Signed by the Speaker of the House

    5/22/2026House

  3. Signed by the President of the Senate

    5/22/2026Senate

  4. Sent to the Governor

    5/22/2026House

  5. House Considered Senate Amendments - Result was to Concur - Repass

    4/21/2026House

  6. House Considered Senate Amendments - Result was to Laid Over Daily

    4/20/2026House

  7. Senate Third Reading Passed - No Amendments

    4/17/2026Senate

  8. Senate Second Reading Passed with Amendments - Committee

    4/16/2026Senate

  9. Senate Second Reading Laid Over to 04/16/2026 - No Amendments

    4/14/2026Senate

  10. Senate Committee on Health & Human Services Refer Amended - Consent Calendar to Senate Committee of the Whole

    4/9/2026Senate

  11. Introduced In Senate - Assigned to Health & Human Services

    3/19/2026Senate

  12. House Third Reading Passed - No Amendments

    3/16/2026House

  13. House Second Reading Special Order - Passed with Amendments - Floor

    3/13/2026House

  14. House Committee on Health & Human Services Refer Unamended to House Committee of the Whole

    3/10/2026House

  15. Introduced In House - Assigned to Health & Human Services

    2/19/2026House

Bill Text

  • Engrossed

    PDF

  • Final Act

    PDF

  • Introduced

    PDF

  • Reengrossed

    PDF

  • Rerevised

    PDF

  • Revised

    PDF

  • Senate Health & Human Services Preamend

    PDF

  • Signed Act

    PDF

Related Bills

Back to State Legislation